C4X Discovery Results Video With CEO Clive Dix

21st November 2018 | C4X Discovery Holdings plc

C4X Discovery Holdings (LON:C4XD) this morning announced its full year results. Revenues rose to over £7m from £143,000 the previous year. Revenue gains were driven by a deal signed with Indivior (LON:INDV).  Clive Dix discusses highlights from the period, and discusses the outlook for the Group:

C4X Discovery Results Video With CEO Clive Dix

 

In March this year, C4X entered into a licensing deal with Indivior for its  Orexin-1 antagonist programme, which targets addiction. The deal included a $10 million upfront payment with up to $284 million paybale subject to milestones being reached.

C4X  develops cutting edge healthcare tech to drive drug discovery.

The full results can be found at C4X’s Investor Relations website.

C4X Discovery Investor Videos

Clive Dix, CEO of C4X updating investors on Five Minute Pitch TV

Click here to view C4X investor relations films